Campbell introduces Encuity venture

Share this article:

Biopharma consultancy Campbell Alliance launched a market research and analytics group, one that could pose a threat to traditional MR firms.

The subsidiary, called Encuity Research, will be led by Campbell veteran Michael Turner.

It combines three components: SDI Health promotional and medical audit businesses that the consulting firm's parent, inVentiv Health, bought from IMS Health; service lines that came to Campbell after it was bought by inVentiv in 2011—RapidRecall (message effectiveness), Metropolitan Area Promotional Audit (syndicated audits of promotional activity), VisionCare (contact-lens market data), as well as a custom KOL mapping service; and Campbell's custom MR capability to support consulting projects.
Share this article:

Email Newsletters

More in Features

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...